Efficacy and Safety of Trabeculectomy in Pakistani Patients with Mitomycin C delivered via Sub Tenon Injection versus Conventional Soaked Sponges

Author:

Qazi Hina1,Abdul Zehra1,Ayub Rida1,Damji Karim1,Mahar Salim1

Affiliation:

1. Aga Khan University Hospital

Abstract

Abstract Purpose: Trabeculectomy with Mitomycin C (MMC) is a frequent choice for surgical intervention to effectively control intraocular pressure (IOP) in glaucoma. This study aims to compare the efficacy and safety of trabeculectomy in Pakistani patients with MMC administration by sponges versus sub-tenon injection. Methods: A retrospective cohort study was conducted to analyze consecutive patients who underwent trabeculectomy with MMC at Aga Khan University Hospital, Karachi, Pakistan Complete success was defined as achieving an IOP of ≤ 15 mmHg at least one year one year post-surgery without additional anti-glaucoma medication. Qualified success was defined as IOP≤ 15 mmHg at least one year one year post-surgery with additional anti-glaucoma medications. Results: A total of 102 eyes from 67 patients were included in the study. Among the participants, 49%underwent trabeculectomy with MMC using the traditional sponges, while 51% underwent trabeculectomy with MMC via sub-tenon injection. At 12 months, the study revealed an overall success rate of 59% in the subtenon injection group versus 41% in the sponges group (p = 0.159) in controlling IOP. However, the sub-tenon injection group exhibited a trend towards lower IOP, achieving 100% complete surgical success versus 37% in the conventional sponges group along with displaying a lower frequency of post-operative complications (57% in the sponges-treated group vs 43% in the sub tenon injection group). Conclusion: Both MMC application techniques in trabeculectomy demonstrate similar efficacy and safety in Pakistani patients. The sub-tenon injection method emerges as a potentially safer alternative, offering benefits in lowering IOP and ensuring complete treatment success without the need for additional medications.

Publisher

Research Square Platform LLC

Reference22 articles.

1. World Health Organization. Blindness and vision impairment. World Health Organization; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment.

2. Glaucoma in Asia: regional prevalence variations and future projections;Chan EWe, Li X;British Journal of Ophthalmology,2016

3. A comprehensive study capturing vision loss burden in Pakistan (1990–2025): Findings from the Global Burden of Disease (GBD) 2017 study;Hassan B;PloS one,2019

4. Coleman AL. Advances in glaucoma treatment and management: surgery. Investigative ophthalmology & visual science. 2012;53(5):2491-4. DOI: 10.1167/iovs.12-9483l

5. Glaucoma surgery with soaked sponges with mitomycin c vs sub-tenon injection: Short-term outcomes;Guimarães ME;Journal of Current Glaucoma Practice,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3